Ivan Solovič - Concepedia

Author

Ivan Solovič

Also Known As

Alena Skrahina, Catherine W.M. Ong, I Solovic, I. Solovic, I. Solovič, Ivan Solovi, Ivan Solovic, Ivan Solovič, Masoud Dara, Voicu Tudorache

115

Publications

5.4K

Citations

H-Index

Concepts

All Affiliations

Catholic University in Ruzomberok Queen Mary University of London Centro Hospitalar de Vila Nova de Gaia University of Sassari Barts Health NHS Trust

About

Ivan Solovič is an author at Catholic University in Ruzomberok specializing in medicine, public health, and tuberculosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1K
2	Public Health	8	8	1.7K
3	Nursing	2	2	91
4	Health Sciences	1	1	81
5	Clinical Immunology	1	1	512

Ivan Solovič

Publications

3.7K

Citations

H-Index

Page 1

	Year	Citations
COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study Florian Götzinger, Begoña Santiago, Antoni Noguera‐Julián, The Lancet Child & Adolescent Health Epidemiological TrendVirus EpidemiologyPediatric EpidemiologyGlobal HealthMulticentre Cohort Study	2020	1.3K
LTBI: latent tuberculosis infection or lasting immune responses to <i>M. tuberculosis</i> ? A TBNET consensus statement Ulrich Mack, Giovanni Battista Migliori, Martina Sester, European Respiratory Journal	2009	592
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement Ivan Solovič, Martina Sester, Juan J. Gómez‐Reino, European Respiratory Journal Clinical ImmunologyImmunodeficienciesTuberculosis PreventionImmunologyImmune Regulation	2010	512
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report Edvardas Danila, Andrei Maryandyshev, Margareth Pretti Dalcolmo, European Respiratory Journal	2019	168
Challenges in diagnosing extrapulmonary tuberculosis in the European Union, 2011 Ivan Solovič, Jerker Jonsson, M Korzeniewska- Koseła, Eurosurveillance DiagnosisPleural EffusionDiagnosticsMedical DiagnosisPneumothorax	2013	161
Risk Assessment of Tuberculosis in Contacts by IFN-γ Release Assays. A Tuberculosis Network European Trials Group Study Jean-Pierre Zellweger, Giovanni Sotgiu, Michael S. Block, American Journal of Respiratory and Critical Care Medicine	2015	110
Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB Simon Tiberi, Marie-Christine Payen, Giovanni Sotgiu, European Respiratory Journal	2016	99
ERS/ECDC Statement: European Union standards for tuberculosis care, 2017 update Giovanni Battista Migliori, Giovanni Sotgiu, Senia Rosales-Klintz, European Respiratory Journal	2018	85
Comparison of effectiveness and safety of imipenem/clavulanate-<i>versus</i>meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB Simon Tiberi, Giovanni Sotgiu, Lia D’Ambrosio, European Respiratory Journal Tuberculosis PreventionPharmacotherapyAntimicrobial ChemotherapyXdr-tb CasesDrug Resistance	2016	81
Tuberculosis care among refugees arriving in Europe: a ERS/WHO Europe Region survey of current practices Masoud Dara, Ivan Solovič, Giovanni Sotgiu, European Respiratory Journal Tuberculosis PreventionRefugee StatusPreventive MedicinePreventive TreatmentPublic Health	2016	79

Page 1